Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating combination chemotherapy for recurrent or refractory cervical cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED